1Buy.AI | $3,900,000 | (Feb 3, 2026)
PranaX | $17,000,000 | (Feb 3, 2026)
DexMat | $5,000,000 | (Feb 3, 2026)
Certified by Founder
Lodge
CatalYm GmbH
start up
Germany
- Martinsried, Bayern
- 16/07/2024
- Series D
- $150,000,000
Developing innovative immunotherapies to transform cancer patients’ lives by engaging their own immune systems.
- Industry Biotechnology Research
- Website https://www.catalym.com/
- LinkedIn https://www.linkedin.com/company/catalym/
Related People
Phil L'HuillierFounder
United Kingdom -
Greater London, England
Specialties: CEO, Leadership, Corporate Development & strategy, Clinical Development, Business Development in biotechnology and pharmaceutical sectors
Prenosis | $20,000,000 | (Feb 3, 2026)
CloudForge AI | $3,950,000 | (Feb 3, 2026)
Linq | $20,000,000 | (Feb 3, 2026)
Breezy | $10,000,000 | (Feb 3, 2026)
Poetiq | $45,800,000 | (Feb 3, 2026)
JJG Machining Group | $30,000,000 | (Feb 3, 2026)
Principle | $2,000,000 | (Feb 3, 2026)
BizTrip AI | $1,500,000 | (Feb 3, 2026)
Co-reactive | $7,754,157 | (Jan 30, 2026)